Credence Research Logo
Inquiry Before Buying
Home » Medical Devices » Respiratory Syncytial Virus (RSV) Diagnostics Market

Respiratory Syncytial Virus (RSV) Diagnostics Market By Technology (RSV Molecular Diagnostics, RSV Monoclonal Antibodies, Immunoassays, Differential Light Scattering, Artificial Intelligence, Liposomes, Flow Cytometry, Chromatography, Diagnostic Imaging, Gel Microdroplets) By End Users ( Hospitals, Nursing Homes, Commercial Laboratories, Public Health Laboratories) — Growth, Future Prospects & Competitive Analysis, 2018-2026

Price: $4999

Published: | Report ID: 9385 | Report Format : PDF

Market Introduction of Respiratory Syncytial Virus (RSV) Diagnostics Market

A mild Respiratory Syncytial Virus (RSV) affects young children’s upper respiratory systems. RSV is frequently characterized by coughing, sore throats, wheezing, and runny noses. The primary diagnostic procedure is a physical examination by the physician. And in extreme cases, the doctor does particular tests, including molecular diagnostics for virus identification, serology tests, and quick antigen detection tests. Initial signs of respiratory syncytial viruses (RVs) include a moderate cold with symptoms such as congestion, a runny nose, coughing, sore throat, and fever. Young newborns may exhibit signs of exhaustion, irritability, and respiratory issues. Under typical circumstances, these symptoms subside after a few days.

Medical Devices

What is the Market Size of Respiratory Syncytial Virus (RSV) Diagnostics in terms of value?

The market for diagnostics for the respiratory syncytial virus (RSV) is expected to grow significantly over the next few years at a CAGR of 8.70%. The market for diagnostics for the respiratory syncytial virus (RSV) was estimated to be worth USD 782.4 million in 2021 and USD 1290.64 million in 2028. The demand for Respiratory Syncytial Virus (RSV) Diagnostics is anticipated to rise significantly in the upcoming years, creating revenue potential for the major market participants of USD 508.24 million between 2022 and 2028.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Which is the key part segment in the Respiratory Syncytial Virus (RSV) Diagnostics Market?

The RSV Molecular Diagnostics segment registered the largest share of total Respiratory Syncytial Virus (RSV) Diagnostics in 2021. The direct fluorescent antibody method, rapid antigen diagnostic test (RADTs), molecular diagnostics, chromatographic immunoassay, diagnostic imaging, gel microdroplets, flow cytometry, and others are products of the respiratory syncytial virus diagnostics market. In addition, gravity-driven testing and oligochromatography are both chromatographic immunoassay (OC) parts. Due to the superior accuracy of molecular methods over other methods, molecular diagnostics made up the greatest portion of the market in 2014. Given that it is the most precise procedure, this approach is the gold standard for diagnosing RSV.

For RSV molecular diagnostics, reverse transcriptase polymerase chain reaction and multiplexed nucleic acid amplification are the most widely used techniques. The Verigene Respiratory Virus Nucleic Acid Test, Simplexa Flu A/B & RSV, and Cepheid Xpert Flu/RSV XC Assay are only a few of the assays based on molecular diagnosis that have been created as of 2014-2015. The increase of genome and proteome research is also projected to lead to the development of novel molecular methods for RSV diagnosis.

Interesting Facts about Respiratory Syncytial Virus (RSV) Diagnostics Industry

  • The top countries in the Respiratory Syncytial Virus (RSV) Diagnostics market are China, Japan, Mexico, Germany, India, and the U.S.
  • The driving factors expected to drive the growth of the respiratory syncytial virus (RSV) diagnostic market during the forecast period are the rise in demand for point-of-care diagnostic tests for RSV-infected individuals and the advancement in the field of specific markers such as proteomics and genomics.
  • The main barrier to the global market for Respiratory Syncytial Virus (RSV) Diagnostics, which is expected to prevent market expansion, is the high operational costs of RSV diagnostics compared to alternative approaches.
  • The Respiratory Syncytial Virus (RSV) Diagnostics market was dominated by North America in terms of volume and value in 2021. 
  • Hospitals are to witness the highest growth during the forecast period.

Who are the Top players/companies in the Respiratory Syncytial Virus (RSV) Diagnostics market in terms of value?

The key players in the global Respiratory Syncytial Virus (RSV) Diagnostics market in terms of value include Abbott Laboratories, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories, Becton, Coris BioConcept, F. Hoffmann-La Roche AG, DiaSorin Molecular LLC (DiaSorin Inc), Quest Diagnostics Incorporated, Quidel Corporation, Merck KgaA, and Thermo Fisher Scientific. These major businesses are concentrating on new product advances as well as technological innovation to improve the quality of their manufacturing of Respiratory Syncytial Virus (RSV) Diagnostics and win a competitive market share on a global scale. Several local and global businesses are also making big investments to broaden their product lines and increase sales.

Which are the Top 10 Countries in the Respiratory Syncytial Virus (RSV) Diagnostics Market?

In the global Respiratory Syncytial Virus (RSV) Diagnostics market, the major countries are China, Japan, Mexico, Germany, India, the U.S., Canada, the U.K., France, and Italy. During the research period, it is anticipated that the United States will control a sizeable portion of the market in North America. Untapped potential, constantly improving healthcare infrastructure, economic growth, and increasing patient awareness contribute to these regions’ rapid growth. For instance, Allplex RV Master Assay acquired the European CE-IVD certification and approval from Australia’s Therapeutic Goods Administration, according to a report from Seegene Inc. in April 2022. It can discriminate between two types of respiratory syncytial viruses and 21 targets for 19 different respiratory viruses.

Which is the key End-user used in the Respiratory Syncytial Virus (RSV) Diagnostics Market?

The hospital category dominated the Respiratory Syncytial Virus (RSV) Diagnostics market in 2021. The RSV Diagnostic market’s primary end user in healthcare facilities. The main factors influencing the growth of this market are the rising prevalence of RSV disease in children, the rising need for RSV diagnosis in hospitals and clinics, and the rising usage of PoC molecular diagnostic equipment in hospitals and clinics for RSV diagnosis. Due to the prevalence of RSV infection in neonates and babies, treatment for these populations must be regulated with 24-hour surveillance, which leads to a high hospitalization rate in cases of RSV infection.

What are the Major Driving Factors for the Respiratory Syncytial Virus (RSV) Diagnostics Market?

The main drivers expected to fuel the growth of the respiratory syncytial virus (RSV) diagnostic market during the forecast period is the increase in demand for point-of-care diagnostic tests for people infected with RSV and the advancement in the field of specific markers like proteomics and genomics. The respiratory syncytial virus (RSV) diagnostic market is expected to develop due to the rising number of RSV infections. Additionally, it is predicted that the growing preference for molecular diagnostics over immunoassays will temper the expansion of the respiratory syncytial virus (RSV) diagnostic market. Even The development of new technologies, including multiplex viral testing, thin layer-based amperometric enzyme immunoassays (EIA), and filament-based antibody detection tests, is nearly complete. PoC devices will soon align with nucleic acid amplification methods and loop-mediated isothermal amplification. This will make it possible to conduct testing using a one-step kit that only needs the inclusion of a patient sample. Additionally, nanoparticle technology, which could increase viral detection four times over RT-PCR (the current gold standard), is being developed.

What are the Major Restraints for the Respiratory Syncytial Virus (RSV) Diagnostics Market?

The high operational costs of Respiratory Syncytial Virus (RSV) Diagnostics as compared to other techniques is the primary restraint of the worldwide Respiratory Syncytial Virus (RSV) Diagnostics market, which is anticipated to impede market expansion. The market’s growth is also significantly hampered by the high capital expenditure needed to purchase the requisite equipment and the cost of Respiratory Syncytial Virus (RSV) Diagnostics. Due to the lowering immunoassay detection limits, the respiratory syncytial virus (RSV) diagnostic market is anticipated to grow steadily throughout the forecast period.

Which Region Dominated the World Respiratory Syncytial Virus (RSV) Diagnostics Market?

In 2021, North America dominated the global Respiratory Syncytial Virus (RSV) Diagnostics market and accounted for a major market revenue share. The rising incidence of respiratory syncytial virus infections in the region, expanding R&D activities, rising investments, and support for government initiatives and key market players’ initiatives are the main factors propelling the growth of the North American respiratory syncytial virus (RSV) market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

During the research period, it is anticipated that the United States will control a sizeable portion of the market in North America. For instance, according to the article named Increased Interseasonal Respiratory Syncytial Virus Activity in End Users of the Southern United States,” released by the Centers for Disease Control and Prevention in June 2021, RSV causes, on average, in the United States 58,000 hospitalizations, 100–500 deaths among children under the age of 5, and 177,000 hospitalizations, 14,000 deaths among adults 65 years of age or older. As a result, the prevalence of RSV infections is rising nationwide, increasing demand for diagnostics and propelling the market. Due to their excellent accuracy, sensitivity, and specificity, popular products utilized in the region include chromatographic immunoassays which have seen a sharp rise in demand. An increase in strategic alliances between pharmaceutical giants and in vitro diagnostic manufacturing companies are anticipated to boost the market for companion diagnostics, signifying enormous potential.

Segmentation of Global Respiratory Syncytial Virus (RSV) Diagnostics Market-

Global Respiratory Syncytial Virus (RSV) Diagnostics Market – By Technology

  • RSV Molecular Diagnostics
  • RSV Monoclonal Antibodies
  • Immunoassays
  • Differential Light Scattering
  • Artificial Intelligence
  • Liposomes
  • Flow Cytometry
  • Chromatography
  • Diagnostic Imaging
  • Gel Microdroplets

Global Respiratory Syncytial Virus (RSV) Diagnostics Market – By End Users

  • Hospitals
  • Nursing Homes
  • Commercial Laboratories
  • Public Health Laboratories

Global Respiratory Syncytial Virus (RSV) Diagnostics Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Respiratory Syncytial Virus (RSV) Diagnostics Market
2.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By Technology
2.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, By End Users

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value, 2016-2028, (US$ Mn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Major Industry Challenges
3.2.3. Key Growth Pockets
3.3. Attractive Investment Proposition,2021
3.3.1. Technology
3.3.2. End Users
3.3.3. Geography
3.4. Porter’s Five Forces Analysis
3.4.1. Threat of New Entrants
3.4.2. Bargaining Power of Buyers/Consumers
3.4.3. Bargaining Power of Suppliers
3.4.4. Threat of Substitute Types
3.4.5. Intensity of Competitive Rivalry
3.5. Value Chain Analysis

4. Market Positioning of Key Players, 2021
4.1. Company market share of key players, 2021
4.2. Competitive Benchmarking
4.3. Geographical Presence Analysis
4.4. Major Strategies Adopted by Key Players
4.4.1. Key Strategies Analysis
4.4.2. Mergers and Acquisitions
4.4.3. Partnerships
4.4.4. Product Launch
4.4.5. Geographical Expansion
4.4.6. Others

5. COVID 19 Impact Analysis
5.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Pre Vs Post COVID 19, 2019 – 2028
5.2. Impact on Import & Export
5.3. Impact on Demand & Supply

6. Global
6.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
6.1.1. Overview
6.1.2. RSV Molecular Diagnostics
6.1.3. RSV Monoclonal Antibodies
6.1.4. Immunoassays
6.1.5. Differential Light Scattering
6.1.6. Artificial Intelligence
6.1.7. Liposomes
6.1.8. Flow Cytometry
6.1.9. Chromatography
6.1.10. Diagnostic Imaging
6.1.11. Gel Microdroplets
6.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
6.2.1. Overview
6.2.2. Hospitals
6.2.3. Nursing Homes
6.2.4. Commercial Laboratories
6.2.5. Public Health Laboratories

7. North America
7.1. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
7.1.1. U.S.
7.1.2. Canada
7.2. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
7.2.1. Overview
7.2.2. RSV Molecular Diagnostics
7.2.3. RSV Monoclonal Antibodies
7.2.4. Immunoassays
7.2.5. Differential Light Scattering
7.2.6. Artificial Intelligence
7.2.7. Liposomes
7.2.8. Flow Cytometry
7.2.9. Chromatography
7.2.10. Diagnostic Imaging
7.2.11. Gel Microdroplets
7.3. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
7.3.1. Overview
7.3.2. Hospitals
7.3.3. Nursing Homes
7.3.4. Commercial Laboratories
7.3.5. Public Health Laboratories
7.3.6. U.S.
7.4. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
7.4.1.1. U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
7.4.1.2. U.S. Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
7.4.1.3. U.S. Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
7.4.2. Canada
7.4.2.1. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
7.4.2.2. Canada Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
7.4.2.3. Canada Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)

8. Europe
8.1. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
8.1.1. UK
8.1.2. France
8.1.3. Germany
8.1.4. Italy
8.1.5. Spain
8.1.6. Rest of Europe
8.2. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
8.2.1. Overview
8.2.2. RSV Molecular Diagnostics
8.2.3. RSV Monoclonal Antibodies
8.2.4. Immunoassays
8.2.5. Differential Light Scattering
8.2.6. Artificial Intelligence
8.2.7. Liposomes
8.2.8. Flow Cytometry
8.2.9. Chromatography
8.2.10. Diagnostic Imaging
8.2.11. Gel Microdroplets
8.3. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
8.3.1. Overview
8.3.2. Hospitals
8.3.3. Nursing Homes
8.3.4. Commercial Laboratories
8.3.5. Public Health Laboratories
8.4. Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
8.4.1. Germany
8.4.1.1. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. Germany Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.1.3. Germany Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.2. France
8.4.2.1. France Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. France Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.2.3. France Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.3. UK
8.4.3.1. UK Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.3.2. UK Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.3.3. UK Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.4. Italy
8.4.4.1. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.4.2. Italy Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.4.3. Italy Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.5. Spain
8.4.5.1. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.5.2. Spain Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.5.3. Spain Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
8.4.6. Rest of Europe
8.4.6.1. Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.6.2. Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
8.4.6.3. Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)

9. Asia Pacific
9.1. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
9.1.1. China
9.1.2. Japan
9.1.3. South Korea
9.1.4. India
9.1.5. South East Asia
9.1.6. Rest of Asia Pacific
9.2. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
9.2.1. Overview
9.2.2. RSV Molecular Diagnostics
9.2.3. RSV Monoclonal Antibodies
9.2.4. Immunoassays
9.2.5. Differential Light Scattering
9.2.6. Artificial Intelligence
9.2.7. Liposomes
9.2.8. Flow Cytometry
9.2.9. Chromatography
9.2.10. Diagnostic Imaging
9.2.11. Gel Microdroplets
9.3. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
9.3.1. Overview
9.3.2. Hospitals
9.3.3. Nursing Homes
9.3.4. Commercial Laboratories
9.3.5. Public Health Laboratories
9.4. Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
9.4.1. China
9.4.1.1. China Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. China Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.1.3. China Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.2. Japan
9.4.2.1. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. Japan Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.2.3. Japan Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.3. India
9.4.3.1. India Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. India Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.3.3. India Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.4. South Korea
9.4.4.1. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. South Korea Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.4.3. South Korea Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.5. South-East Asia
9.4.5.1. South-East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. South-East Asia Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.5.3. South-East Asia Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
9.4.6. Rest of Asia Pacific
9.4.6.1. Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)

10. Latin America
10.1. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
10.1.1. Brazil
10.1.2. Mexico
10.1.3. Rest of Latin America
10.2. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
10.2.1. Overview
10.2.2. RSV Molecular Diagnostics
10.2.3. RSV Monoclonal Antibodies
10.2.4. Immunoassays
10.2.5. Differential Light Scattering
10.2.6. Artificial Intelligence
10.2.7. Liposomes
10.2.8. Flow Cytometry
10.2.9. Chromatography
10.2.10. Diagnostic Imaging
10.2.11. Gel Microdroplets
10.3. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
10.3.1. Overview
10.3.2. Hospitals
10.3.3. Nursing Homes
10.3.4. Commercial Laboratories
10.3.5. Public Health Laboratories
10.4. Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
10.4.1. Brazil
10.4.1.1. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.1.2. Brazil Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
10.4.1.3. Brazil Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
10.4.2. Mexico
10.4.2.1. Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.2.2. Mexico Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
10.4.2.3. Mexico Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
10.4.3. Rest of Latin America
10.4.3.1. Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.3.2. Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
10.4.3.3. Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)

11. Middle East & Africa
11.1. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028(US$ Mn)
11.1.1. GCC Countries
11.1.2. South Africa
11.1.3. Rest of Middle East & Africa
11.2. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028(US$ Mn)
11.2.1. Overview
11.2.2. RSV Molecular Diagnostics
11.2.3. RSV Monoclonal Antibodies
11.2.4. Immunoassays
11.2.5. Differential Light Scattering
11.2.6. Artificial Intelligence
11.2.7. Liposomes
11.2.8. Flow Cytometry
11.2.9. Chromatography
11.2.10. Diagnostic Imaging
11.2.11. Gel Microdroplets
11.3. Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028(US$ Mn)
11.3.1. Overview
11.3.2. Hospitals
11.3.3. Nursing Homes
11.3.4. Commercial Laboratories
11.3.5. Public Health Laboratories
11.4. Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Bn)
11.4.1. GCC Countries
11.4.1.1. GCC Countries il Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.1.2. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
11.4.1.3. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
11.4.1.4. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By Deployment, 2016-2028 (US$ Bn)
11.4.1.5. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By Platform, 2016-2028 (US$ Bn)
11.4.1.6. GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics, By End User, 2016-2028 (US$ Bn)
11.4.2. South Africa
11.4.2.1. South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.2.2. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
11.4.2.3. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
11.4.2.4. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Deployment, 2016-2028 (US$ Bn)
11.4.2.5. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Platform, 2016-2028 (US$ Bn)
11.4.2.6. South Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End User, 2016-2028 (US$ Bn)
11.4.3. Rest of Middle East & Africa and Africa
11.4.3.1. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.3.2. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Technology, 2016-2028 (US$ Bn)
11.4.3.3. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End Users, 2016-2028 (US$ Bn)
11.4.3.4. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Deployment, 2016-2028 (US$ Bn)
11.4.3.5. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By Platform, 2016-2028 (US$ Bn)
11.4.3.6. Rest of Middle East & Africa and Africa Respiratory Syncytial Virus (RSV) Diagnostics, By End User, 2016-2028 (US$ Bn)

12. Company Profiles
12.1. Abbott Laboratories
12.2. Becton
12.3. Dickinson and Company
12.4. BioMérieux SA
12.5. Bio-Rad Laboratories
12.6. Coris BioConcept
12.7. DiaSorin Molecular LLC (DiaSorin Inc)
12.8. F. Hoffmann-La Roche AG
12.9. Merck KgaA
12.10. Quest Diagnostics Incorporated
12.11. Quidel Corporation
12.12. Thermo Fisher Scientific
12.13. Others

List of Figures

FIG. 1 Global Respiratory Syncytial Virus (RSV) Diagnostics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Segmentation
FIG. 4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2021 (US$ Mn)
FIG. 5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2021 (US$ Mn)
FIG. 6 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Geography, 2021 (US$ Mn)
FIG. 7 Attractive Investment Proposition, by Technology, 2021
FIG. 8 Attractive Investment Proposition, by End Users, 2021
FIG. 9 Attractive Investment Proposition, by Geography, 2021
FIG. 10 Global Market Positioning of Key Respiratory Syncytial Virus (RSV) Diagnostics Market Manufacturers, 2019
FIG. 11 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value Contribution, By Technology, 2021 & 2028 (Value %)
FIG. 12 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by RSV Molecular Diagnostics, Value, 2016-2028 (US$ Mn)
FIG. 13 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by RSV Monoclonal Antibodies, Value, 2016-2028 (US$ Mn)
FIG. 14 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Immunoassays, Value, 2016-2028 (US$ Mn)
FIG. 15 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Differential Light Scattering, Value, 2016-2028 (US$ Mn)
FIG. 16 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Artificial Intelligence, Value, 2016-2028 (US$ Mn)
FIG. 17 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Liposomes, Value, 2016-2028 (US$ Mn)
FIG. 18 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Flow Cytometry, Value, 2016-2028 (US$ Mn)
FIG. 19 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Chromatography, Value, 2016-2028 (US$ Mn)
FIG. 20 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Diagnostic Imaging, Value, 2016-2028 (US$ Mn)
FIG. 21 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Gel Microdroplets, Value, 2016-2028 (US$ Mn)
FIG. 22 Global Respiratory Syncytial Virus (RSV) Diagnostics Market Value Contribution, By End Users, 2021 & 2028 (Value %)
FIG. 23 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Hospitals, Value, 2016-2028 (US$ Mn)
FIG. 24 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Nursing Homes, Value, 2016-2028 (US$ Mn)
FIG. 25 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Commercial Laboratories, Value, 2016-2028 (US$ Mn)
FIG. 26 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Public Health Laboratories, Value, 2016-2028 (US$ Mn)
FIG. 27 U.S. Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 28 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 29 U.K. Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 30 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 31 France Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 32 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 33 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 34 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 35 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 36 China Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 37 India Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 38 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 39 Southeast Asia Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 40 Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 41 Middle East & Africa & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 42 South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 43 GCC Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 44 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 45 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 46 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 47 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)
FIG. 48 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, 2016-2028 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Respiratory Syncytial Virus (RSV) Diagnostics Market
TABLE 2 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Competitive Benchmarking, 2021
TABLE 3 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Key Strategies Analysis, 2021
TABLE 5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 6 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 7 Global Respiratory Syncytial Virus (RSV) Diagnostics Market, by Geography, 2016-2028 (US$ Mn)
TABLE 8 North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 9 North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 10 North America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country, 2016-2028 (US$ Mn)
TABLE 11 US Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 12 US Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 13 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 14 Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 15 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 16 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 17 Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 18 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 19 Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 20 France Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 21 France Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 22 UK Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 23 UK Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 24 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 25 Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 26 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 27 Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 28 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 29 Rest of Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$
TABLE 30 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 31 Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Bn)
TABLE 32 China Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 33 China Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 34 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 35 Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 36 India Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 37 India Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 38 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 39 South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 40 South East Asia Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 41 Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 42 Rest of Asia Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 43 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 44 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 45 Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 46 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 47 Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 48 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 49 Mexico Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 50 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 51 Rest of Latin America Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 52 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Mn)
TABLE 53 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End Users, 2016-2028 (US$ Mn)
TABLE 54 Middle East & Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Country/Region, 2016-2028 (US$ Mn)
TABLE 55 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 56 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by Deployment, 2016-2028 (US$ Bn)
TABLE 57 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by Platform, 2016-2028 (US$ Bn)
TABLE 58 GCC Countries Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 59 South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 60 South Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)
TABLE 61 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by Technology, 2016-2028 (US$ Bn)
TABLE 62 Rest of Middle East and Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, by End User, 2016-2028 (US$ Bn)

Frequently Asked Questions

How does COVID-19 Impact the global Respiratory Syncytial Virus (RSV) Diagnostics market?

Respiratory Syncytial Virus (RSV) Diagnostics Market also suffered from the COVID 19 pandemic, which resulted in an increase in revenue generated in 2020 as growth brought on by the region’s rapidly expanding COVID-19 cases and the usage of RSV diagnostic kits to identify COVID-19.

Which is the leading market for Respiratory Syncytial Virus (RSV) Diagnostics?

The market for diagnostics for the respiratory syncytial virus (RSV) was dominated by North America.

What are the key drivers for the growth of the Respiratory Syncytial Virus (RSV) Diagnostics market?

The rise in the demand for point-of-care diagnostic tests for RSV-infected people and the advancement in the field of specific markers such as proteomics and genomics are the main factors that are anticipated to propel the growth of the respiratory syncytial virus (RSV) diagnostic market during the forecast period.

Which is the major segment in Respiratory Syncytial Virus (RSV) Diagnostics Market by Technology?

RSV Molecular Diagnostics had a major share in 2021.

Which is the major segment in Respiratory Syncytial Virus (RSV) Diagnostics Market by End Users?

The Hospitals had a major share in the global market in 2021.

Related Reports

United States Artificial Intelligence (AI) in Medical Diagnostics Market

Published:
Report ID: 36390

United States Ventilator Market

Published:
Report ID: 36387

United States Bariatric Surgery Devices Market

Published:
Report ID: 36381

Ventilator Market

Published:
Report ID: 36256

Endodontic Reparative Cement Market

Published:
Report ID: 36240

United States Scalp Cooling System Market

Published:
Report ID: 36100

Japan Compression Socks Market

Published:
Report ID: 36024

Chromatography Syringes Market

Published:
Report ID: 36008

Gas Chromatography Market

Published:
Report ID: 36002

Cerebral Angiography Market

Published:
Report ID: 35929

Asia Pacific Cosmetic Surgery Market

Published:
Report ID: 35562

Drug Delivery Technologies Market

Published:
Report ID: 5510

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.

Request Free Sample

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207

support

24/7 Research Support

sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

Get Methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN
Request Free Sample